Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06303115 · ClinicalTrials.gov registry record · NA
CSD231005 Nicotine Pouch Biomarkers of Exposure
A NA study, sponsored by RAI Services Company.
- Completed
- Registry status
- NA
- Development phase
- 200
- Enrollment target
NCT06303115 is a NA study that has completed, run by RAI Services Company. The registered enrollment target is 200 participants.
The verdict
NCT06303115, a NA study, has completed, sponsored by RAI Services Company.
- COMPLETED
- Registry status
- NA
- Development phase
- 200 participants
- Enrollment target
Study Summary
This will be a multi center open label, randomized, controlled, switching parallel-group study designed to assess changes in select biomarkers of exposure (BoE) in generally healthy smokers following a 5 day in-clinic switch to use of nicotine Pouch investigational products (IPs) compared to continued usual brand (UB) cigarette smoking or smoking abstinence.
Interventions
- OTHER Nicotine Pouch P1312914, 4 mg nicotine
- OTHER Nicotine Pouch P1312915, 8 mg nicotine
- OTHER Nicotine Pouch P1013215, 8 mg nicotine
- OTHER Nicotine Pouch P1013218, 10 mg nicotine
- OTHER Nicotine Pouch P1012919, 12 mg nicotine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2024-08-22 |
| Est. Completion | 2025-01-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06303115
The ClinicalTrials.gov registry entry for NCT06303115 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is RAI Services Company, which has 42 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Nicotine Pouch P1312914, 4 mg nicotine is the first listed.
NCT06303115 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06303115 about?
NCT06303115 is a clinical study titled "CSD231005 Nicotine Pouch Biomarkers of Exposure". This will be a multi center open label, randomized, controlled, switching parallel-group study designed to assess changes in select biomarkers of exposure (BoE) in generally healthy smokers following a 5 day in-clinic switch to use of nicotine Pouch investigational products (IPs) compared to continu...
What is the current status of trial NCT06303115?
This trial is currently completed. It is a NA study. The enrollment target is 200 participants. The study started on 2024-08-22. Estimated completion is 2025-01-15.
What interventions are being tested in trial NCT06303115?
The interventions under investigation include: Nicotine Pouch P1312914, 4 mg nicotine (OTHER), Nicotine Pouch P1312915, 8 mg nicotine (OTHER), Nicotine Pouch P1013215, 8 mg nicotine (OTHER), Nicotine Pouch P1013218, 10 mg nicotine (OTHER), Nicotine Pouch P1012919, 12 mg nicotine (OTHER).
Who is sponsoring clinical trial NCT06303115?
This trial is sponsored by RAI Services Company, which has 42 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.